Drugs / LY2525623
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01018810 | Dec 2009 → May 2010 | psoriasis | Eli Lilly and Company | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LY2525623 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01018810 ↗ |
| Route | Intravenous | “administered intravenously” NCT01018810 ↗ |